GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » Total Liabilities

Dicot AB (XSAT:DICOT) Total Liabilities : kr7.84 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dicot AB Total Liabilities?

Dicot AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr7.84 Mil.

Dicot AB's quarterly Total Liabilities increased from Sep. 2023 (kr5.62 Mil) to Dec. 2023 (kr9.16 Mil) but then declined from Dec. 2023 (kr9.16 Mil) to Mar. 2024 (kr7.84 Mil).

Dicot AB's annual Total Liabilities increased from Dec. 2021 (kr3.42 Mil) to Dec. 2022 (kr7.01 Mil) and increased from Dec. 2022 (kr7.01 Mil) to Dec. 2023 (kr9.16 Mil).


Dicot AB Total Liabilities Historical Data

The historical data trend for Dicot AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB Total Liabilities Chart

Dicot AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 1.27 1.95 3.42 7.01 9.16

Dicot AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.10 5.39 5.62 9.16 7.84

Dicot AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Dicot AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.163+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=9.16

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=53.555-44.393
=9.16

Dicot AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.838+(0+-0.0010000000000003
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=7.84

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=38.591-30.754
=7.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dicot AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Dicot AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Dicot AB (XSAT:DICOT) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37
Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (XSAT:DICOT) Headlines

No Headlines